ストックスクリーナーアプリを入手
7.18
2.57%
0.18
アフターアワーズ：
7.30
0.12
+1.67%
前日終値:
$7.00
開ける：
$6.99
24時間の取引高:
641.26K
Relative Volume:
2.47
時価総額：
$156.96M
収益：
$52.55M
当期純損益:
$-23.69M
株価収益率:
-7.6383
EPS:
-0.94
ネットキャッシュフロー:
$-15.29M
1週間 パフォーマンス:
+2.57%
1か月 パフォーマンス:
-7.12%
6か月 パフォーマンス:
+79.95%
1年 パフォーマンス:
+250.24%
1日の値動き範囲:
$6.7525
$7.305
1週間の範囲:
$6.6472
$7.305
52週間の値動き範囲:
$1.78
$7.95
Exagen Inc Stock (XGN) Company Profile
XGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.18 | 153.02M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
424.98 | 162.60B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.79 | 147.08B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
518.71 | 43.52B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.36 | 35.27B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
163.25 | 28.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-04-15 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cowen | Outperform |
| 2019-10-14 | 開始されました | William Blair | Outperform |
すべてを表示
Exagen Inc (XGN) 最新ニュース
Exagen Appoints Chas McKhann to Board of Directors - TipRanks
Exagen Inc. Appoints Chas McKhann to Board of Directors - AInvest
Exagen appoints Chas McKhann to board of directors - Investing.com Australia
Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan
Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
What makes Exagen Inc. stock price move sharplyFree Expert Investment Advice - Newser
How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser
Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest
Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Quiver Quantitative
Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan
Why Exagen Inc. stock attracts strong analyst attentionTrending Stock Alert - Newser
Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener
Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener
Exagen Insider Ups Holding During Year - Yahoo
Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest
Exagen announces resale of up to 1.15M shares - MSN
Exagen appoints Michael Mahler as CSO - TipRanks
Leading Autoimmune Researcher Dr. Mahler Joins Exagen: 300+ Publications and Game-Changing Diagnostic Patents - Stock Titan
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus
Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen Inc (XGN) 財務データ
収益
当期純利益
現金流量
EPS
2.54%
3.38%
大文字化:
|
ボリューム (24 時間):